Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Managing Infection Risk and Safety Monitoring with Anti-CD20 MS Disease Modifying Therapy
2
Evaluating Oral BTK Inhibitor Remibrutinib in Phase 3 Study for Generalized Myasthenia Gravis: The RELIEVE Trial
3
Clinical Opinion: EU Approval of Tolebrutinib Signals New Direction for Nonrelapsing Secondary Progressive MS
4
Multidimensional Cognitive Training Improves Cognition, Mood, and Quality of Life in Postoperative Glioma Patients, Trial Finds
5